Member feedback indicates some confusion may exist around which Endorsement for Scheduled Medicines (ESM) pathway is available to pursue. To help clarify this issue, we have put together some Q+As to bear in mind.
Q1. What does the Ahpra website say on this issue?
The Australian Health Practitioner Regulation Agency (Ahpra) website says:
Registration standard: Endorsement for scheduled medicines – Effective 1 August 2018
To meet the requirements for this pathway you must provide evidence that you hold one of the following qualifications:
an approved qualification for endorsement for scheduled medicines, or
another qualification that the Board considers to be substantially equivalent to, or based on similar competencies to, an approved qualification for endorsement for scheduled medicines.
Q2. What is an ‘approved qualification’?
If we look at option 1 above, just what does an ‘approved qualification’ mean in this context?
The Podiatry Board states that an approved qualification is “obtained by completing a podiatry program of study that has been accredited by the accreditation authority for the podiatry profession, and subsequently approved by the Board as providing a qualification for the purpose of endorsement for scheduled medicines under Pathway A of the Registration standard: Endorsement for scheduled medicines.”
Q3. I’m a recent graduate, does that mean I qualify under ‘Pathway A’?
As a recent graduate it is likely that part of your undergraduate studies meets the Podiatry Board of Australia’s ‘approved qualifications’ requirement for you to start pathway B. University courses are not yet designed to meet the pathway A requirement.
Q4. Where can I find more information on Pathway A compared to Pathway B?
Q5. Where can I deep dive into this issue further?
Dr Kristin Graham from the University of South Australia wrote an article – which was published here in the Journal of Foot and Ankle Research. It maps out the endorsement for scheduled medicines process for podiatrists.